> top > docs > PubMed:9736046 > annotations
TextAE configuration unavailable!

PubMed:9736046 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-106 Sentence denotes Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
TextSentencer_T2 107-227 Sentence denotes MRP-1/CD9, KAI1/CD82, and ME491/CD63, have been reported to be associated with the metastatic potential of solid tumors.
TextSentencer_T3 228-371 Sentence denotes The aim of this study was to determine whether their expression in tumor tissues is a useful indicator for prognosis in breast cancer patients.
TextSentencer_T4 372-432 Sentence denotes We studied 109 breast cancer patients who underwent surgery.
TextSentencer_T5 433-559 Sentence denotes Quantitative reverse transcription-polymerase chain reaction analysis was performed to evaluate the expression of these genes.
TextSentencer_T6 560-613 Sentence denotes The results were confirmed with immunohistochemistry.
TextSentencer_T7 614-661 Sentence denotes All of the carcinomas were ME491/CD63 positive.
TextSentencer_T8 662-704 Sentence denotes Thirty-six tumors were MRP-1/CD9 negative.
TextSentencer_T9 705-934 Sentence denotes The disease-free survival rate and the 5-year survival rate of patients with MRP-1/CD9-negative tumors were both significantly lower than that in patients with MRP-1/ CD9-positive tumors (P = 0.0005 and P = 0.0380, respectively).
TextSentencer_T10 935-977 Sentence denotes Sixty-five tumors were KAI1/CD82 negative.
TextSentencer_T11 978-1142 Sentence denotes The disease-free survival rate of patients with KAI1/CD82-negative tumors was significantly lower than that of patients with KAI1/CD82-positive tumors (P = 0.0065).
TextSentencer_T12 1143-1328 Sentence denotes Cox regression analysis demonstrated that MRP-1/CD9 status (P = 0.0016) and KAI1/CD82 status (P = 0.0234) were useful indicators for the disease-free survival of breast cancer patients.
TextSentencer_T13 1329-1576 Sentence denotes The disease-free survival rate and 5-year survival rate of patients with either MRP-1/CD9-negative or KAI1/CD82-negative tumors were both significantly lower than patients who were positive for both genes (P = 0.0003 and P = 0.0292, respectively).
TextSentencer_T14 1577-1693 Sentence denotes The expression of MRP-1/CD9 and KAI1/CD82 genes are useful indicators of a poor prognosis in breast cancer patients.
T1 0-106 Sentence denotes Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
T2 107-227 Sentence denotes MRP-1/CD9, KAI1/CD82, and ME491/CD63, have been reported to be associated with the metastatic potential of solid tumors.
T3 228-371 Sentence denotes The aim of this study was to determine whether their expression in tumor tissues is a useful indicator for prognosis in breast cancer patients.
T4 372-432 Sentence denotes We studied 109 breast cancer patients who underwent surgery.
T5 433-559 Sentence denotes Quantitative reverse transcription-polymerase chain reaction analysis was performed to evaluate the expression of these genes.
T6 560-613 Sentence denotes The results were confirmed with immunohistochemistry.
T7 614-661 Sentence denotes All of the carcinomas were ME491/CD63 positive.
T8 662-704 Sentence denotes Thirty-six tumors were MRP-1/CD9 negative.
T9 705-934 Sentence denotes The disease-free survival rate and the 5-year survival rate of patients with MRP-1/CD9-negative tumors were both significantly lower than that in patients with MRP-1/ CD9-positive tumors (P = 0.0005 and P = 0.0380, respectively).
T10 935-977 Sentence denotes Sixty-five tumors were KAI1/CD82 negative.
T11 978-1142 Sentence denotes The disease-free survival rate of patients with KAI1/CD82-negative tumors was significantly lower than that of patients with KAI1/CD82-positive tumors (P = 0.0065).
T12 1143-1328 Sentence denotes Cox regression analysis demonstrated that MRP-1/CD9 status (P = 0.0016) and KAI1/CD82 status (P = 0.0234) were useful indicators for the disease-free survival of breast cancer patients.
T13 1329-1576 Sentence denotes The disease-free survival rate and 5-year survival rate of patients with either MRP-1/CD9-negative or KAI1/CD82-negative tumors were both significantly lower than patients who were positive for both genes (P = 0.0003 and P = 0.0292, respectively).
T14 1577-1693 Sentence denotes The expression of MRP-1/CD9 and KAI1/CD82 genes are useful indicators of a poor prognosis in breast cancer patients.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 47-51 gene:3732 denotes CD82
T1 83-96 disease:C0678222 denotes breast cancer
T2 47-51 gene:3732 denotes CD82
T3 83-96 disease:C0006142 denotes breast cancer
T4 139-143 gene:967 denotes CD63
T5 214-226 disease:C0280100 denotes solid tumors
T6 133-138 gene:967 denotes ME491
T7 214-226 disease:C0280100 denotes solid tumors
T8 123-127 gene:3732 denotes CD82
T9 214-226 disease:C0280100 denotes solid tumors
R1 T0 T1 associated_with CD82,breast cancer
R2 T2 T3 associated_with CD82,breast cancer
R3 T4 T5 associated_with CD63,solid tumors
R4 T6 T7 associated_with ME491,solid tumors
R5 T8 T9 associated_with CD82,solid tumors

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
9736046-1#16#20#gene3732 123-127 gene3732 denotes CD82
9736046-1#26#31#gene967 133-138 gene967 denotes ME491
9736046-1#32#36#gene967 139-143 gene967 denotes CD63
9736046-1#107#119#diseaseC0280100 214-226 diseaseC0280100 denotes solid tumors
16#20#gene3732107#119#diseaseC0280100 9736046-1#16#20#gene3732 9736046-1#107#119#diseaseC0280100 associated_with CD82,solid tumors
26#31#gene967107#119#diseaseC0280100 9736046-1#26#31#gene967 9736046-1#107#119#diseaseC0280100 associated_with ME491,solid tumors
32#36#gene967107#119#diseaseC0280100 9736046-1#32#36#gene967 9736046-1#107#119#diseaseC0280100 associated_with CD63,solid tumors

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 83-89 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 348-354 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 387-393 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 1305-1311 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T5 1670-1676 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T6 301-308 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T638 1185-1190 gene:4363 denotes MRP-1
T639 1305-1318 disease:C0006142 denotes breast cancer
R1 T638 T639 associated_with MRP-1,breast cancer
R2 T638 T639 associated_with MRP-1,breast cancer
R3 T638 T639 associated_with MRP-1,breast cancer
R4 T638 T639 associated_with MRP-1,breast cancer
R5 T638 T639 associated_with MRP-1,breast cancer
R6 T638 T639 associated_with MRP-1,breast cancer
R7 T638 T639 associated_with MRP-1,breast cancer
R8 T638 T639 associated_with MRP-1,breast cancer

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 301-308 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
PD-UBERON-AE-B_T2 83-89 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 348-354 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 387-393 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T5 1305-1311 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T6 1670-1676 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast